Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DSSTox_CID_31

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_31

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,876,925Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncology Pharma Has Received the Committed Funding to Perform IND-Enabling Work
    Oncology Pharma Has Received the Committed Funding to Perform IND-Enabling Work

    13 Sep 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/oncology-pharma-inc-has-received-the-committed-funding-to-perform-all-necessary-ind-enabling-preclinical-work-for-its-first-lead-candidate-a-dactinomycin-nanoemulsion-drug-product/

    BIOSPACE
    13 Sep 2021
    Share Share
    Mylan Lab’s Generic Dactinomycin Receives Approval In US
    Mylan Lab’s Generic Dactinomycin Receives Approval In US

    13 Nov 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203385

    FDA
    13 Nov 2017
    Share Share
    Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
    Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection

    19 Sep 2016

    // EDQM

    https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf

    EDQM
    19 Sep 2016
    Share Share